Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory

被引:595
作者
Cramer, JA
Perrine, K
Devinsky, O
Bryant-Comstock, L
Meador, T
Hermann, B
机构
[1] VA Connecticut Healthcare Syst, W Haven, CT USA
[2] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA
[3] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA
[4] NYU, Dept Neurol, New York, NY 10016 USA
[5] NYU, Hosp Joint Dis, Comprehens Epilepsy Program, New York, NY 10003 USA
[6] Glaxo Wellcome, Int Pharmacoecon Res, Res Triangle Pk, NC USA
[7] Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA
[8] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA
关键词
health-related quality-of-life; dimensions of health; construct validity; quality-of-life in epilepsy inventory; epilepsy; translocations;
D O I
10.1111/j.1528-1157.1998.tb01278.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: We report the development of a questionnaire to assess health-related quality-of-life (HRQOL) in people with epilepsy and the process of cross-cultural translations of the questionnaire. Methods: A sample of 304 adults with epilepsy from 25 seizure clinics in the United States was used to derive an abbreviated questionnaire focusing on epilepsy-related issues from a longer, 89-item instrument (QOLIE-89). A rigorous forward-backward-forward system was used for cross-cultural translation. Results: A 31-item questionnaire (QOLIE-31, version 1.0) resulted, comprising seven subscales covering general and epilepsy-specific domains. Subscale and total scores can be calculated. The subscales were grouped into two factors: Emotional/Psychological Effects (seizure worry, overall QOL, emotional well-being, energy/fatigue subscales) and Medical/Social Effects (medication effects, work-driving-social limits, cognitive function subscales). Cross-cultural translations were made from U.S.-English into Danish, Dutch, German, Canadian French, French, Italian, Spanish, Swedish, and U.K. English Versions 1.1. Conclusions: Our results support the reliability and validity of the QOLIE-31 (U.S.-English version 1.0) as a measure of HRQOLIE. Cross-cultural translations into nine other languages make it feasible to use the QOLIE-31 (version 1.1) in multinational clinical trials after validation in each population or concurrent with the clinical trial.
引用
收藏
页码:81 / 88
页数:8
相关论文
共 23 条
[1]  
Andrew F., 1976, SOCIAL INDICATORS WE
[2]  
[Anonymous], 1992, POMS PROFILE MOOD ST
[3]   THE INITIAL DEVELOPMENT OF A HEALTH-RELATED QUALITY-OF-LIFE MODEL AS AN OUTCOME MEASURE IN EPILEPSY [J].
BAKER, GA ;
SMITH, DF ;
DEWEY, M ;
JACOBY, A ;
CHADWICK, DW .
EPILEPSY RESEARCH, 1993, 16 (01) :65-81
[4]   TESTING THE VALIDITY OF THE EUROQOL AND COMPARING IT WITH THE SF-36 HEALTH SURVEY QUESTIONNAIRE [J].
BRAZIER, J ;
JONES, N ;
KIND, P .
QUALITY OF LIFE RESEARCH, 1993, 2 (03) :169-180
[5]   A brief questionnaire to screen for quality of life in epilepsy: The QOLIE-10 [J].
Cramer, JA ;
Perrine, K ;
Devinsky, O ;
Meador, K .
EPILEPSIA, 1996, 37 (06) :577-582
[6]  
CRAMER JA, 1994, NEUROL CLIN, V12, P1
[7]   A METHOD OF QUANTIFICATION FOR THE EVALUATION OF ANTI-EPILEPTIC DRUG-THERAPY [J].
CRAMER, JA ;
SMITH, DB ;
MATTSON, RH ;
ESCUETA, AVD ;
COLLINS, JF ;
BROWNE, TR ;
CRILL, WE ;
HOMAN, RW ;
MAYERSDORF, A ;
MCCUTCHEN, CB ;
MCNAMARA, JO ;
ROSENTHAL, NP ;
TREIMAN, DM ;
WILDER, BJ ;
WILLIAMSON, PD .
NEUROLOGY, 1983, 33 (03) :26-37
[8]  
Cramer JA, 1996, QUALITY LIFE PHARMAC, P909
[9]  
Cramer Joyce, 1995, Epilepsia, V36, P93
[10]   DEVELOPMENT OF THE QUALITY-OF-LIFE IN EPILEPSY INVENTORY [J].
DEVINSKY, O ;
VICKREY, BG ;
CRAMER, J ;
PERRINE, K ;
HERMANN, B ;
MEADOR, K ;
HAYS, RD .
EPILEPSIA, 1995, 36 (11) :1089-1104